Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BI 653048 BS H3PO4 Capsule Assessing Endotoxin-induced Inflammatory Response in Healthy Male Subjects
Clinical trial NCT02224105 · COMPLETED
Trial details
- NCT number
- NCT02224105
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2010-05-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.